Home › Acute Lymphoblastic Leukemia › South Carolina › Charleston
Acute Lymphoblastic Leukemia clinical trials in Charleston, SC
4 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Medical University of South Carolina, Charleston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Medical University of South Carolina, Charleston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Medical University of South Carolina, Charleston
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Medical University of South Carolina, Charleston
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Chicago, IL19 studies
- Atlanta, GA19 studies
- Philadelphia, PA16 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Post-Traumatic Stress Disorder16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer15 studies
- Cardiovascular Disease15 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.